Skip to Photo Next
1/1 and 1/1
Name: Meakin Nick.
Age: 60, but why is it important to that?
What is your company’s name?
Ltd. of Aqualution Devices.
Where it’s based.
Duns in the Borders of Scotland.
What does it produce?
In hypochloric acid research, processing and application, Aqualution is the industry leader. Our products and solutions provide safe and effective full infection prevention for a number of industries, substantially reducing cross-contamination, reducing risk and improving the safety of people who use the facilities. They are used to keep both individuals and locations infection-free in areas such as workplaces, warehouses, classrooms, hospitals and nursing homes. We also work in the fields of food safety, fruit decontamination, salads, vegetables and herbs, and animal husbandry, particularly dairy and chicken farming.
Via our proprietary electrodialysis process, Aqualution technology produces hypochlorous acid from water and salt to produce a stable, fast-acting biocide for many different applications.
Two main products are made by the company:
An on-demand biocide that is produced at the point of use on-site, e.g. in poultry farming and in the production and processing of food.
A bottled commodity that can be sold in a number of industries, including nursing, pet care, management of facilities and dentistry. It is sold and licensed to others to sell under their labels under the Aqualution brand name.
To whom is it sold?
Hospitals, nursing homes and groups of nursing homes, dentists, educational schools, offices, catering companies, farms and agriculture, stores, sports facilities.
What turnover does it have?
On an annualized basis, Aqualution has seen a 560 percent rise in revenue to £ 4 million as a direct result of the Covid 19 coronavirus.
How many workers does the organization have?
When was the firm founded?
In September 2009.
Why the move did you make?
The pharmaceutical company where the original research was conducted was sold in 2008 and the new owners were not interested, so I led a management buyout and we developed the company from there. The potential of the concept was very strong, and while it took a while to hit seven-figure sales, we are now accelerating as a lot of high-value research and development is getting to market.
What were you doing before you took the leap?
I have worked in many sectors, including automotive, food manufacturing, aerospace, aquaculture and pharmaceuticals, and have held senior positions in a number of major companies over the past 30 years.
How did you raise startup funding?
From business angels, two of whom are still with us.
What was your biggest breakthrough?
The first was convincing Marks and Spencer that we were a credible company developing food safety solutions for them. As you can imagine, Marks and Spencer is very protective of its brand and reputation as a leader in food quality and food safety issues. Achieving such credibility and trust that they invited us to develop specific answers to new food safety challenges for them was a big step in growing the company’s food safety division.
What do you enjoy most about running the company?
The diversity of applications for our molecule means that we are involved in a wide range of projects and meet people with different insights from all over the world. There aren’t many companies where one day you’re on a mango plantation in Ghana, the next day you’re working on developing robotic harvesting systems in America, and the next day you’re in an elderly care facility in Newcastle.
Our core team has also been together from day one and we all get on really well.
What are your ambitions for the company?
To build on what we’ve achieved so far in biocides and move into the pharmaceutical space, where we have a number of exciting R&D projects that have the potential to make a real difference in treating difficult-to-cure diseases.
What could the Westminster and/or Scottish governments do to help?
We have received great support from Scottish Enterprise, but in terms of next stage